-
Je něco špatně v tomto záznamu ?
Biobanks in the era of personalized medicine: objectives, challenges, and innovation: Overview
J. Kinkorová,
Jazyk angličtina Země Nizozemsko
Typ dokumentu časopisecké články, přehledy
NLK
BioMedCentral Open Access
od 2012
PubMed Central
od 2010 do Před 1 rokem
ProQuest Central
od 2010-03-01 do 2018-12-31
Open Access Digital Library
od 2010-01-01
Open Access Digital Library
od 2011-01-01
Health & Medicine (ProQuest)
od 2010-03-01 do 2018-12-31
- Publikační typ
- časopisecké články MeSH
- přehledy MeSH
Biobanks are an important compound of personalized medicine and strongly support the scientific progress in stratification of population and biomarker discovery and validation due to progress in personalized medicine. Biobanks are an essential tool for new drug discoveries and drug development. Biobanks play an important role in the whole process of patient prevention and prediction, follow-up, and therapy monitoring and optimalization. Biobanks have the specificity in that they cover multidisciplinary approach to the human health combining biological and medical approaches, as well as informative bioinformatics technologies, computationing, and modeling. The importance of biobanks has during the last decade increased in variety and capacity from small collections of samples to large-scale national or international repositories. Collected samples are population-based, disease-specific or rare diseases originating from a diverse profile of individuals. There are various purposes of biobanks, such as diagnostics, pharmacology, or research. Biobanks involve, store, and operate with specific personal information, and as a consequence, such a diversity of biobanking is associated with a broad spectrum of ethical and legal issues. Biobanks are an international phenomenon because any single country, state, or society at the moment is not able to cover all issues involving the whole biobank problematic. Biobanks have an enormous innovative potential in the whole process of biomedical research in the twenty-first century.
Faculty Hospital in Pilsen Edvarda Benese 1128 13 305 99 Plzen Czech Republic
Medical Faculty Charles University in Pilsen Lidicka 1 301 00 Plzen Czech Republic
Citace poskytuje Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc16010842
- 003
- CZ-PrNML
- 005
- 20210316124957.0
- 007
- ta
- 008
- 160408s2016 ne f 000 0|engg|
- 009
- AR
- 024 7_
- $a 10.1186/s13167-016-0053-7 $2 doi
- 024 7_
- $a 10.1186/s13167-016-0053-7 $2 doi
- 035 __
- $a (PubMed)26904153
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a ne
- 100 1_
- $a Kinkorová, Judita, $d 1960- $u Faculty Hospital in Pilsen, Edvarda Benese 1128/13, 305 99 Plzen, Czech Republic ; Medical Faculty Charles University in Pilsen, Lidicka 1, 301 00 Plzen, Czech Republic. $7 xx0001268
- 245 10
- $a Biobanks in the era of personalized medicine: objectives, challenges, and innovation: Overview / $c J. Kinkorová,
- 520 9_
- $a Biobanks are an important compound of personalized medicine and strongly support the scientific progress in stratification of population and biomarker discovery and validation due to progress in personalized medicine. Biobanks are an essential tool for new drug discoveries and drug development. Biobanks play an important role in the whole process of patient prevention and prediction, follow-up, and therapy monitoring and optimalization. Biobanks have the specificity in that they cover multidisciplinary approach to the human health combining biological and medical approaches, as well as informative bioinformatics technologies, computationing, and modeling. The importance of biobanks has during the last decade increased in variety and capacity from small collections of samples to large-scale national or international repositories. Collected samples are population-based, disease-specific or rare diseases originating from a diverse profile of individuals. There are various purposes of biobanks, such as diagnostics, pharmacology, or research. Biobanks involve, store, and operate with specific personal information, and as a consequence, such a diversity of biobanking is associated with a broad spectrum of ethical and legal issues. Biobanks are an international phenomenon because any single country, state, or society at the moment is not able to cover all issues involving the whole biobank problematic. Biobanks have an enormous innovative potential in the whole process of biomedical research in the twenty-first century.
- 655 _2
- $a časopisecké články $7 D016428
- 655 _2
- $a přehledy $7 D016454
- 773 0_
- $w MED00181668 $t The EPMA journal $x 1878-5077 $g Roč. 7, č. 1 (2016), s. 4
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/26904153 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y a $z 0
- 990 __
- $a 20160408 $b ABA008
- 991 __
- $a 20210316124953 $b ABA008
- 999 __
- $a ind $b bmc $g 1114271 $s 935210
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2016 $b 7 $c 1 $d 4 $e 2015 $i 1878-5077 $m The EPMA journal $n EPMA J $x MED00181668
- LZP __
- $a Pubmed-20160408